Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection

Award Number: R01AI179037
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/24/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection - PROJECT SUMMARY One of the biggest challenges facing the tuberculosis field is the heterogeneity of TB disease presentation. Only a small percentage of individuals infected with Mycobacterium tuberculosis go on to develop an acute infection. While several important tuberculosis co-morbidities have been identified (i.e. HIV co-infection, smoking, malnu- trition, diabetes), we are still unable to accurately predict whether a tuberculosis patient is at high risk for devel- oping severe disease. For decades, we have understood that the way in which Mtb-infected macrophages die plays a key role in dictating Mtb outcomes in vivo. Apoptosis, an “immunologically silent” form of cell death is generally considered anti-bacterial; apoptosis limits bacterial spread and does not release high amounts of im- munogenic DAMPs and PAMPs. Necrosis, an inflammatory form of cell death, promotes Mtb survival and spread and elicits harmful immunopathology. One would predict that a tuberculosis patient with macrophages that are prone to necrosis would be likely to experience severe inflammation in response to Mtb infection. Our preliminary data demonstrate that a common human SNP in a mitochondrial-associated gene called LRRK2 promotes a new hyperinflammatory type of necrosis in response to Mtb infection. This cell death was dubbed gasdermin D-mediated necroptosis, as it requires the pore forming protein gasdermin D and results in activa- tion of RIPK1/RIPK3/MLKL and cell death via necroptosis. This mutation (Lrrk2G2019S) promotes excessive mito- chondrial reactive oxygen species (mtROS) production and mtROS alone is sufficient to promote gasdermin D- mediated necroptosis. Building on these findings, this proposal will test the hypothesis that mitochondrial dysfunction and oxidative stress drive Mtb-infected macrophages to undergo inflammatory forms of cell death and constitute a new, important “co-morbidity” for tuberculosis patients. The goal of this proposal is to mechanistically define how oxidative stress promotes pathogenic cell death modalities during Mtb infection of macrophages and mice. Here, two models of high mtROS will be leveraged (exogenous mtROS via menadi- one treatment and the human disease-associated SNP Lrrk2G2019S) to mechanistically define how oxidative stress can repurpose cell death proteins in primary murine macrophages. Aim 1 will investigate the ability of LRRK2 kinase activity to directly activate necroptosome proteins and promote gasdermin D-mediated necroptosis. Aim 2 will define how various cellular stresses license N-GSDMD association with mitochondrial phospholipids to promote gasdermin D-mediated necroptosis. Aim 3 will examine the role of lipid oxidation in dictating cell death modality usage during Mtb infection. If successful, this proposal will define the cellular triggers of hyperinflam- matory cell death during Mtb infection of macrophages and identify novel points for therapeutic intervention that may be more efficacious to target in TB patients with underlying conditions or genetics linked to mitochondrial dysfunction and oxidative stress.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $792,355 )
2026	2026	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	000	4	5/19/2026	NON-COMPETING CONTINUATION	$792,355
														Subtotal = $792,355

Issue Date FY: 2025 ( Subtotal = $829,648 )
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	004	3	8/19/2025	NON-COMPETING CONTINUATION	$0
2025	2025	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	003	3	4/10/2025	NON-COMPETING CONTINUATION	$769,168
2025	2024	VANDERBILT UNIVERSITY MEDICAL CENTER	1161 21ST AVE S STE D3300 MCN	NASHVILLE	TN	37232	DAVIDSON	USA	Allergy and Infectious Diseases Research	001	2	11/21/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$660,642
2025	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	002	1	3/25/2025	NEW	$0
2025	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	000	1	11/21/2024	NEW	-$600,162
														Subtotal = $829,648

Issue Date FY: 2024 ( Subtotal = $600,163 )
2024	2024	TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER	6003 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Allergy and Infectious Diseases Research	000	1	6/26/2024	NEW	$600,163
														Subtotal = $600,163

Grand Total All Awards = $2,222,166

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection

Award Number: R01AI179037

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/24/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer